Actiframe

Actiframe, a technology spinout from the University of St Andrews, specializes in developing Metal Organic Frameworks (MOFs) to enhance vascular access devices. These patented materials release nitric oxide (NO) to prevent thrombosis and spasm, common issues in arterial procedures. Actiframe's products are designed for medical device manufacturers, allowing them to integrate antithrombotic and vasodilatory features into their vascular diagnostic and procedural tools. The company operates under cGMP protocols, ensuring high-quality production of MOFs at scale. Actiframe's technology is particularly relevant for devices like introducer sheaths and catheters used in percutaneous coronary intervention (PCI), a primary treatment for heart disease. By reducing risk and discomfort for patients and lowering costs for clinicians, Actiframe aims to facilitate both routine and complex medical procedures. The company collaborates closely with clients to ensure product compatibility and optimal performance, leveraging over a decade of experience in incorporating MOF powders into various healthcare products.

Keywords: Metal Organic Frameworks, nitric oxide, thrombosis prevention, vasodilation, vascular devices, medical manufacturers, cGMP protocols, percutaneous coronary intervention, healthcare products, University of St Andrews.